Anti-EGFR or Bevacizumab in first line treatment of RAS wild type metastatic colorectal neoplasm (RwtMCRC): meta-analysis of randomized clincal trials

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 26; p. vi36
Main Authors	Tamburini, E., Rudnas, B., Gianni, L., Drudi, F., Nicoletti, S., Santelmo, C., Ridolfi, C., Pasini, G., Fabbri, P., Papi, M., Tassinari, D.
Format	Journal Article
Language	English
Published	01.10.2015
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534
DOI:	10.1093/annonc/mdv340.02